How hyperglycemia promotes atherosclerosis: molecular mechanisms

Aronson, Doron; Rayfield, Elliot J.
January 2002
Cardiovascular Diabetology;2002, Vol. 1, p1
Academic Journal
Both type I and type II diabetes are powerful and independent risk factors for coronary artery disease (CAD), stroke, and peripheral arterial disease. Atherosclerosis accounts for virtually 80% of all deaths among diabetic patients. Prolonged exposure to hyperglycemia is now recognized a major factor in the pathogenesis of atherosclerosis in diabetes. Hyperglycemia induces a large number of alterations at the cellular level of vascular tissue that potentially accelerate the atherosclerotic process. Animal and human studies have elucidated three major mechanisms that encompass most of the pathological alterations observed in the diabetic vasculature: 1) Nonenzymatic glycosylation of proteins and lipids which can interfere with their normal function by disrupting molecular conformation, alter enzymatic activity, reduce degradative capacity, and interfere with receptor recognition. In addition, glycosylated proteins interact with a specific receptor present on all cells relevant to the atherosclerotic process, including monocyte-derived macrophages, endothelial cells, and smooth muscle cells. The interaction of glycosylated proteins with their receptor results in the induction of oxidative stress and proinflammatory responses 2) oxidative stress 3) protein kinase C (PKC) activation with subsequent alteration in growth factor expression. Importantly, these mechanisms may be interrelated. For example, hyperglycemiainduced oxidative stress promotes both the formation of advanced glycosylation end products and PKC activation.


Related Articles

  • Role of BMI in the Association of the TCF7L2 rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study. Kucharska-Newton, Anna M.; Monda, Keri L.; Bielinski, Suzette J.; Boerwinkle, Eric; Rea, Thomas D.; Rosamond, Wayne D.; Pankow, James S.; Köttgen, Anna; Heiss, Gerardo; North, Kari E. // Journal of Obesity;2010, Vol. 2010, p1 

    We examined the association of variation in the type 2 diabetes risk-conferring TCF7L2 gene with the risk of incident coronary heart disease (CHD) among the lean, overweight, and obese members of the Atherosclerosis Risk in Communities (ARIC) Study cohort. Cox proportional hazard regression...

  • Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism. Gazzaruso, Carmine; Garzaniti, Adriana; Giordanetti, Stefano; Falcone, Colomba; Fratino, Pietro // Cardiovascular Diabetology;2002, Vol. 1, p5 

    Background: There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism are associated with angiographically assessed...

  • Role of Hyperglycaemia in Pathogenesis of Diabetic Cardiovascular Disease. Zervou, Sevasti; Khan, Michael // Vascular Disease Prevention;Apr2007, Vol. 4 Issue 2, p125 

    The accumulated wisdom of the last decade has fuelled a view of diabetes as an unusually severe form of cardiovascular disease (CVD) with a poor prognosis. Diabetic patients expect an up to 3-fold increase in coronary heart disease (CHD) events, independent of other traditional CVD risk factors,...

  • Diabetes has a greater effect on mortality in women with CHD.  // Geriatrics;Dec93, Vol. 48 Issue 12, p58 

    Reports on the findings of a study regarding the effects of diabetes on patients with coronary heart disease. `Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease,' by Y Liao, RS Cooper, JK Ghali, et al.

  • Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population. Bansal, Dipika; Nayakallu, Ramya S. R.; Gudala, Kapil; Vyamasuni, Rajavikram; Bhansali, Anil // Diabetes & Metabolism Journal;Aug2015, Vol. 39 Issue 4, p321 

    Background: The aim of the study is to evaluate the concurrence between Framingham Risk score (FRS) and United Kingdom Prospective Diabetes Study (UKPDS) risk engine in identifying coronary heart disease (CHD) risk in newly detected diabetes mellitus patients and to explore the characteristics...

  • Lung Function and Risk of Type 2 Diabetes and Fatal and Nonfatal Major Coronary Heart Disease Events: Possible Associations With Inflammation. WANNAMETHEE, S. GOYA; SHAPER, A. GERALD; RUMLEY, ANN; SATTAR, NAVEED; WHINCUP, PETER H.; THOMAS, MARY C.; LOWE, GORDON D. // Diabetes Care;Sep2010, Vol. 33 Issue 9, p1990 

    OBJECTIVE -- We prospectively examined the relationship between lung function and risk of type-2 diabetes and fatal and nonfatal coronary heart disease (CHD) events and investigated the hypothesis that inflammation may underlie these associations. RESEARCH DESIGN AND METHODS-- A prospective...

  • Progression of microalbuminuria to proteinuria in type 1 diabetes. Warram, James H.; Scott, Laura J.; Hanna, Linda S.; Wantman, Michael; Cohen, Shmuel E.; Laffel, Lori M.B.; Ryan, Louise; Krolewski, Andrzej S. // Diabetes;Jan2000, Vol. 49 Issue 1, p94 

    Studies the dose-response relationship between exposure to hyperglycemia and progression of microalbuminuria to overt proteinuria of individuals with type 1 diabetes. Incidence rate of progression; Examination of the dose-response curve; Reducing the risk of progression.

  • Diabetes und Demenz. Bahrmann, A.; Bahrmann, P.; Kubiak, T.; Kopf, D.; Oster, P.; Sieber, C.C.; Daniel, W.G. // Zeitschrift für Gerontologie und Geriatrie;Jan2012, Vol. 45 Issue 1, p17 

    Diabetes mellitus is a known risk factor for cognitive dysfunction and dementia. Chronic hyperglycemia, genetic predisposition, arterial hypertension, hyperlipoproteinemia, micro- and macrovascular diseases, and depression play a major role in the development of cognitive dysfunction. Both...

  • Parental History of Diabetes Modifies the Association Between Abdominal Adiposity and Hyperglycemia. Van Dam, Rob M.; Boer, Jolanda M.A.; Feskens, Edith J.M.; Seidell, Jaap C. // Diabetes Care;Aug2001, Vol. 24 Issue 8, p1454 

    Presents information on a study which examined whether the association between abdominal obesity and hyperglycemia differs according to the presence of a parental history of diabetes. Research design and methods; Factors associated with hyperglycemia; Results and conclusion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics